Most studies of delayed tuberculosis diagnosis focus on the adverse effect of time elapsed between the onset of symptoms to reaching diagnosis and subsequent patient outcomes and control of community transmission.
Dec 28, 2015
0
16
A computer model of tuberculosis has shown that approved treatments prescribing antibiotic doses once or twice a week are more likely to lead to drug resistant strains than are daily antibiotic regimens.
Nov 23, 2015
0
0
Scientists have shown how a parasitic worm infection common in the developing world increases susceptibility to tuberculosis. The study demonstrated that treating the parasite reduces lung damage seen in mice that also are ...
Nov 16, 2015
0
39
TB Alliance and its partners announced the start of a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (XDR-TB.) It is the first study to test an all-oral drug regimen, comprised of drugs with ...
May 14, 2015
0
15
A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published ...
Mar 18, 2015
0
5
Drawing inspiration from veterinary medicine, researchers at the University of Washington have helped developed a new prospective approach to diagnosing tuberculosis (TB) - easy-to-obtain oral swab samples, greatly improving ...
Mar 2, 2015
0
134
A report warned Wednesday of a looming tuberculosis-diabetes epidemic as the two diseases intertwine in many countries, driven in part by a rise in unhealthy lifestyles.
Oct 29, 2014
0
0
A clinical drug trial conducted in five Sub-Sahara African countries shows that a shortened (four month) treatment for tuberculosis (TB) is well tolerated and may work well in subsets of TB patients, but overall could not ...
Oct 23, 2014
0
0
(AP)—Despite worsening U.S.-North Korean relations, an American charity is ramping up efforts against an epidemic of multidrug-resistant tuberculosis in the isolated country, where it says it is making inroads in fighting ...
Oct 14, 2014
0
0
The results of a Phase 3 clinical trial involving UCL researchers, called REMoxTB, has found that replacing one of the drugs with the antibiotic moxifloxacin in the standard six-month treatment regimen did not allow the treatment ...
Sep 9, 2014
0
0
